Viewing Study NCT00660920


Ignite Creation Date: 2025-12-25 @ 4:18 AM
Ignite Modification Date: 2026-02-25 @ 9:02 PM
Study NCT ID: NCT00660920
Status: COMPLETED
Last Update Posted: 2018-05-16
First Post: 2008-04-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety Study of AP24534 to Treat Chronic Myelogenous Leukemia (CML) and Other Hematological Malignancies
Sponsor: Ariad Pharmaceuticals
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2008-06
Start Date Type: ACTUAL
Primary Completion Date: 2016-05
Primary Completion Date Type: ACTUAL
Completion Date: 2016-05
Completion Date Type: ACTUAL
First Submit Date: 2008-04-15
First Submit QC Date: None
Study First Post Date: 2008-04-17
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2018-05-15
Last Update Post Date: 2018-05-16
Last Update Post Date Type: ACTUAL